# REMIFENTANIL HYDROCHLORIDE
> **ANDA215635** · Abbreviated New Drug Application (Generic) · Sponsor: NIVAGEN PHARMS INC · Approved 2024-06-28
## Drug
- **FDA Application Number:** ANDA215635
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** REMIFENTANIL HYDROCHLORIDE
- **Generic name:** Remifentanil Hydrochloride
- **Active ingredients:** REMIFENTANIL HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** NIVAGEN PHARMS INC
- **First approval:** 2024-06-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215635)
---
*AI Analytics · CC0 1.0*